IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity.
Molgora M
Nature. 2017 Oct 25;551(7678):110-114. doi: 10.1038/nature24293
Resolving the dark side of therapy-driven cancer cell death.
Bonavita E, Pelly VS, Zelenay S
J Exp Med. 2017 Dec 20;215(1):9-11. doi: 10.1084/jem.20172044
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control.
Böttcher JP
Cell. 2018 Feb 8;172(5):1022-1037.e14. doi: 10.1016/j.cell.2018.01.004
Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors.
Ponzetta A
Cell. 2019 Jun 27;178(2):346-360.e24. doi: 10.1016/j.cell.2019.05.047
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade.
Bonavita E
Immunity. 2020 Nov 20;53(6):1215-1229.e8. doi: 10.1016/j.immuni.2020.10.020
Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy.
Pelly VS
Cancer Discov. 2021 May 24;11(10):2602-2619. doi: 10.1158/2159-8290.CD-20-1815
Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations.
Bell CR
Nat Commun. 2022 Apr 19;13(1):2063. doi: 10.1038/s41467-022-29606-9
The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network.
Volponi C, Gazzillo A, Bonavita E
Cancers (Basel). 2022 Dec 13;14(24)doi: 10.3390/cancers14246151
Chemotactic effect of prorenin on human aortic smooth muscle cells: a novel function of the (pro)renin receptor.
Greco CM
Cardiovasc Res. 2012 Jun 21;95(3):366-74. doi: 10.1093/cvr/cvs204
Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure.
Greco CM, Condorelli G
Nat Rev Cardiol. 2015 May 12;12(8):488-97. doi: 10.1038/nrcardio.2015.71